Latest Insider Transactions at National Health Investors Inc (NHI)
This section provides a real-time view of insider transactions for National Health Investors Inc (NHI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NATIONAL HEALTH INVESTORS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NATIONAL HEALTH INVESTORS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 26
2022
|
Kevin Carlton Pascoe Chief Investment Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
16,065
-32.81%
|
$1,076,355
$67.1 P/Share
|
|
Aug 26
2022
|
Kevin Carlton Pascoe Chief Investment Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,333
+27.24%
|
$971,649
$53.41 P/Share
|
|
Aug 15
2022
|
Robert G Adams Director |
BUY
Open market or private purchase
|
Indirect |
1,500
+1.73%
|
$97,500
$65.93 P/Share
|
|
Dec 30
2021
|
Robert G Adams Director |
BUY
Open market or private purchase
|
Indirect |
2,000
+1.16%
|
$114,000
$57.25 P/Share
|
|
Dec 01
2021
|
Robert T Webb Director |
BUY
Open market or private purchase
|
Indirect |
2,000
+2.35%
|
$102,000
$51.6 P/Share
|
|
Nov 29
2021
|
Robert T Webb Director |
BUY
Open market or private purchase
|
Indirect |
1,000
+2.44%
|
$52,000
$52.86 P/Share
|
|
Sep 30
2021
|
Robert T Webb Director |
BUY
Open market or private purchase
|
Indirect |
2,000
+4.88%
|
$106,000
$53.86 P/Share
|
|
Sep 29
2021
|
D. Eric Mendelsohn CEO and President |
BUY
Open market or private purchase
|
Direct |
2,000
+1.07%
|
$108,000
$54.39 P/Share
|
|
Sep 17
2021
|
Robert T Webb Director |
BUY
Open market or private purchase
|
Indirect |
1,500
+3.9%
|
$85,500
$57.25 P/Share
|
|
Sep 16
2021
|
Robert T Webb Director |
BUY
Open market or private purchase
|
Indirect |
1,500
+4.05%
|
$85,500
$57.5 P/Share
|
|
Sep 14
2021
|
Robert T Webb Director |
BUY
Open market or private purchase
|
Indirect |
1,500
+4.23%
|
$87,000
$58.0 P/Share
|
|
Sep 10
2021
|
Robert T Webb Director |
BUY
Open market or private purchase
|
Indirect |
1,500
+4.41%
|
$87,000
$58.5 P/Share
|
|
Sep 09
2021
|
Robert A Mccabe Jr Director |
BUY
Open market or private purchase
|
Direct |
468
+2.61%
|
$27,612
$59.84 P/Share
|
|
Jul 06
2021
|
W Andrew Adams Director |
SELL
Bona fide gift
|
Indirect |
45,307
-20.38%
|
-
|
|
Jun 17
2021
|
Robert T Webb Director |
BUY
Open market or private purchase
|
Indirect |
1,184
+3.68%
|
$76,960
$65.0 P/Share
|
|
Feb 22
2021
|
W Andrew Adams Director |
SELL
Payment of exercise price or tax liability
|
Direct |
17,344
-47.5%
|
$1,196,736
$69.79 P/Share
|
|
Feb 22
2021
|
W Andrew Adams Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+35.39%
|
$1,200,000
$60.52 P/Share
|
|
Dec 14
2020
|
Robert G Adams Director |
BUY
Open market or private purchase
|
Indirect |
2,000
+1.18%
|
$134,000
$67.75 P/Share
|
|
Nov 18
2020
|
Robert G Adams Director |
BUY
Open market or private purchase
|
Indirect |
4,000
+4.55%
|
$264,000
$66.33 P/Share
|
|
Nov 17
2020
|
Robert G Adams Director |
BUY
Open market or private purchase
|
Indirect |
1,000
+1.24%
|
$66,000
$66.45 P/Share
|